Vitamin E Interactions

High-dose vitamin E supplements can add to the bleeding risk of anticoagulant and antiplatelet medications by inhibiting platelet aggregation and antagonizing vitamin K–dependent clotting factors.

Higher-dose vitamin E (alpha-tocopherol) can inhibit platelet aggregation through a protein kinase C-dependent mechanism, prolonging bleeding times and producing abnormal results on platelet function tests such as the PFA-100, VerifyNow, and light transmission aggregometry. The effect is most pronounced alongside aspirin or other antiplatelet drugs and can complicate a workup for a suspected bleeding disorder.

Vitamin C regenerates the active form of vitamin E. After vitamin E neutralizes a lipid free radical and becomes a tocopheroxyl radical, vitamin C donates an electron at the membrane surface to restore it. This recycling loop extends antioxidant capacity at the lipid-water interface of cell membranes. It is a beneficial synergy, not a risk.

Omega-3 fatty acids (EPA and DHA) are polyunsaturated and highly susceptible to oxidation, which can blunt their cardiovascular and anti-inflammatory benefits. Vitamin E acts as a lipid-soluble antioxidant that helps protect omega-3 fatty acids from peroxidation both during storage and after absorption, which is why most quality fish oils already include a small amount of mixed tocopherols.

Vitamin E and selenium are complementary antioxidants. Selenium is the cofactor for glutathione peroxidase, which clears lipid peroxides and spares vitamin E, while vitamin E intercepts free radicals in membranes and reduces the demand on the selenium-dependent enzyme. The partnership is well established in animal and mechanistic studies; clinical benefit of the combination in people is more limited.